CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Ciprofloxacin In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Ciprofloxacin In Dextrose 5% In Plastic Container launch?
Ciprofloxacin In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Bedford, Hikma Farmaceutica, Hospira, Inforlife, and Teva Pharms. and is included in seven NDAs.
The generic ingredient in CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER is ciprofloxacin. There are thirty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ciprofloxacin In Dextrose 5% In Plastic Container
A generic version of CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as ciprofloxacin by BAXTER HLTHCARE CORP on April 29th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 3 |
Clinical Trials: | 301 |
DailyMed Link: | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Institute of Cancer Research, United Kingdom | Phase 1/Phase 2 |
Prostate Cancer Foundation | Phase 1/Phase 2 |
Shanghai Pulmonary Hospital, Shanghai, China | Phase 4 |
See all CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
Pharmacology for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug Class | Fluoroquinolone Antibacterial Quinolone Antimicrobial |
Mechanism of Action | Cytochrome P450 1A2 Inhibitors |